These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 22001899)
1. Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1). Zheng Y; Guo C; Zhang Y; Qi H; Sun Q; Xu E; Zhang Y; Ma D; Wang Y Int Immunopharmacol; 2011 Dec; 11(12):2188-93. PubMed ID: 22001899 [TBL] [Abstract][Full Text] [Related]
2. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice. Farraj AK; Harkema JR; Kaminski NE Toxicol Sci; 2004 Jun; 79(2):315-25. PubMed ID: 15056815 [TBL] [Abstract][Full Text] [Related]
3. An antagonist for CCR4 alleviates murine allergic rhinitis by intranasal administration. Qi H; Zheng Y; Xu E; Guo C; Zhang Y; Sun Q; Xiao J; Ma D; Wang Y Int Arch Allergy Immunol; 2012; 159(3):297-305. PubMed ID: 22739408 [TBL] [Abstract][Full Text] [Related]
4. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model. Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235 [TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis. Won TB; Quan SH; Kim DY; Rhee CS; Lee CH Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603 [TBL] [Abstract][Full Text] [Related]
6. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis. Han DM; Zhou B; Wang T; Wang XD; Fan EZ Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982 [TBL] [Abstract][Full Text] [Related]
8. The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma. Tian L; Li W; Wang J; Zhang Y; Zheng Y; Qi H; Guo X; Zhang Y; Ma D; Shen H; Wang Y Allergy; 2011 Feb; 66(2):287-97. PubMed ID: 21208220 [TBL] [Abstract][Full Text] [Related]
9. Effect of 5-aminosalicylate on allergic rhinitis model in mice. Kuyama S; Yamamoto A; Sugiyama M; Kakuta H; Sugimoto Y Int Immunopharmacol; 2010 Jun; 10(6):713-6. PubMed ID: 20304104 [TBL] [Abstract][Full Text] [Related]
10. Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Kim YH; Yang TY; Park CS; Ahn SH; Son BK; Kim JH; Lim DH; Jang TY Allergy; 2012 Feb; 67(2):183-90. PubMed ID: 22050307 [TBL] [Abstract][Full Text] [Related]
12. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis. KuoLee R; Zhou H; Harris G; Zhao X; Qiu H; Patel GB; Chen W Clin Exp Allergy; 2008 Jun; 38(6):1003-15. PubMed ID: 18307525 [TBL] [Abstract][Full Text] [Related]
14. In vivo intranasal anti-CD23 treatment inhibits allergic responses in a murine model of allergic rhinitis. Zhou M; Du D; Zhao K; Zheng C J Mol Histol; 2013 Jun; 44(3):327-38. PubMed ID: 23377922 [TBL] [Abstract][Full Text] [Related]
15. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils. Benson M; Strannegård IL; Strannegård O; Wennergren G J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075 [TBL] [Abstract][Full Text] [Related]
16. The role of hypoxia-inducible factor 1α in allergic rhinitis. Mo JH; Kim JH; Lim DJ; Kim EH Am J Rhinol Allergy; 2014; 28(2):e100-6. PubMed ID: 24717944 [TBL] [Abstract][Full Text] [Related]
17. [Influence of aluminum hydroxide adjuvant on a murine model of allergic rhinitis]. Lin L; Yan W; Zhao X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 28(11):780-4. PubMed ID: 25219201 [TBL] [Abstract][Full Text] [Related]
18. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis. Meltzer EO Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557 [TBL] [Abstract][Full Text] [Related]
19. Role of Interleukin-17A on the Chemotactic Responses to CCL7 in a Murine Allergic Rhinitis Model. Zhang YL; Han DH; Kim DY; Lee CH; Rhee CS PLoS One; 2017; 12(1):e0169353. PubMed ID: 28046055 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation. Stebbins KJ; Broadhead AR; Correa LD; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS Eur J Pharmacol; 2010 Jul; 638(1-3):142-9. PubMed ID: 20447387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]